Tony E. Godfrey, PhD
Professor
Boston University School of Medicine
Dept of Surgery
Other Surgery

PhD, Brunel University




Tony E. Godfrey, PhD, Associate Chair, Surgical Research and Associate Professor of Surgery, Boston University School of Medicine, earned a bachelor’s of science degree in biochemistry from Brunel University in England, followed by a doctorate in molecular biology and biochemistry, also from Brunel. He attended the University of California, San Francisco, for postdoctoral fellowships and managed UCSF’s Genome Analysis Core Facility.

Most recently, Dr. Godfrey was a Research Associate Professor in the Department of Surgery at the University of Rochester Medical Center in Rochester, NY. Prior to this he was an Associate Professor of Pathology at Mt. Sinai School of Medicine in New York, NY.

Dr. Godfrey’s research is focused on cancer genetics and molecular pathology. Research projects use state-of-the-art genetic and genomic approaches to address clinical needs in the areas of cancer diagnosis, prognosis and therapy. Currently the major focus of Dr. Godfrey’s research is on Barrett’s esophagus and esophageal adenocarcinoma; a tumor with rapidly increasing incidence in the United States and other western countries. The Godfrey lab works closely with translational research teams comprised of surgeons, pathologists and oncologists in order to develop new molecular approaches to cancer detection, staging and treatment.

Professor
Boston University School of Medicine
Medicine
Computational Biomedicine



Development of diagnostic and prognostic tests for esophageal adenocarcinoma
12/16/2016 - 11/30/2021 (PI)
NIH/National Cancer Institute
5R01CA208599-03

Feasibility of Molecular Cytology for the Management of Barrett's Esophagus
04/21/2015 - 03/31/2018 (PI)
NIH/National Cancer Institute
5R21CA187753-02

Biomarkers for Esophageal cancer Progression and Prognosis
04/01/2013 - 03/31/2018 (PI)
Ontario Institute for Cancer Research Genome Canada


Evaluating the Feasibility of a Molecular Cytology Approach for Management of Patients with Barrett's Esophagus
01/15/2014 - 06/30/2016 (PI)
DeGregorio Foundation


Innovative Approach to Cancer Detection and Treatment Monitoring
04/01/2013 - 03/31/2016 (PI)
NIH/National Cancer Institute
5R21CA172999-02

Biomarkers for Esophageal Cancer progression and prognosis
01/01/2013 - 07/31/2015 (PI)
NIH/National Cancer Institute
7R01CA130853-06




Yr Title Project-Sub Proj Pubs
2019 Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq 1R44CA244049-01
2019 Development of diagnostic and prognostic tests for esophageal adenocarcinoma 5R01CA208599-03
2018 Development of diagnostic and prognostic tests for esophageal adenocarcinoma 5R01CA208599-02
2017 Development of diagnostic and prognostic tests for esophageal adenocarcinoma 1R01CA208599-01A1
2016 Feasibility of Molecular Cytology for the Management of Barrett's Esophagus 5R21CA187753-02
2015 Feasibility of Molecular Cytology for the Management of Barrett's Esophagus 1R21CA187753-01A1
2014 Innovative approach to cancer detection and treatment monitoring 5R21CA172999-02 3
2013 Innovative approach to cancer detection and treatment monitoring 1R21CA172999-01 3
2012 Biomarkers for Esophageal Cancer Progression and Prognosis 5R01CA130853-05 7
2012 Biomarkers for Esophageal Cancer Progression and Prognosis 7R01CA130853-06 7
Showing 10 of 28 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Johansson G, Andersson D, Filges S, Li J, Muth A, Godfrey TE, Ståhlberg A. Corrigendum to "Considerations and quality controls when analyzing cell-free tumor DNA" [Biomol. Detect. Quantif. 17 (2019) 100078]. Biomol Detect Quantif. 2019 Mar; 17:100091. PMID: 31249790.
     
  2. Pennathur A, Godfrey TE, Luketich JD. The Molecular Biologic Basis of Esophageal and Gastric Cancers. Surg Clin North Am. 2019 Jun; 99(3):403-418. PMID: 31047032.
     
  3. Zhou Z, Kalatskaya I, Russell D, Marcon N, Cirocco M, Krzyzanowski PM, Streutker C, Liang H, Litle VR, Godfrey TE, Stein L. Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma. Clin Exp Gastroenterol. 2019; 12:219-229.View Related Profiles. PMID: 31190949.
     
  4. Egyud M, Tejani M, Pennathur A, Luketich J, Sridhar P, Yamada E, Ståhlberg A, Filges S, Krzyzanowski P, Jackson J, Kalatskaya I, Jiao W, Nielsen G, Zhou Z, Litle V, Stein L, Godfrey T. Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma. Ann Thorac Surg. 2019 May 03.View Related Profiles. PMID: 31059681.
     
  5. He HJ, Stein EV, Konigshofer Y, Forbes T, Tomson FL, Garlick R, Yamada E, Godfrey T, Abe T, Tamura K, Borges M, Goggins M, Elmore S, Gulley ML, Larson JL, Ringel L, Haynes BC, Karlovich C, Williams PM, Garnett A, Ståhlberg A, Filges S, Sorbara L, Young MR, Srivastava S, Cole KD. Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements. J Mol Diagn. 2019 Jul; 21(4):658-676. PMID: 31055023.
     
  6. Filges S, Yamada E, Ståhlberg A, Godfrey TE. Impact of Polymerase Fidelity on Background Error Rates in Next-Generation Sequencing with Unique Molecular Identifiers/Barcodes. Sci Rep. 2019 Mar 05; 9(1):3503. PMID: 30837525.
     
  7. Johansson G, Andersson D, Filges S, Li J, Muth A, Godfrey TE, Ståhlberg A. Considerations and quality controls when analyzing cell-free tumor DNA. Biomol Detect Quantif. 2019 Mar; 17:100078. PMID: 30906693.
     
  8. Egyud M, Sridhar P, Devaiah A, Yamada E, Saunders S, Ståhlberg A, Filges S, Krzyzanowski PM, Kalatskaya I, Jiao W, Stein LD, Jalisi S, Godfrey TE. Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer. Head Neck. 2019 May; 41(5):1351-1358.View Related Profiles. PMID: 30554450.
     
  9. Muñoz-Largacha JA, Gower AC, Sridhar P, Deshpande A, O'Hara CJ, Yamada E, Godfrey TE, Fernando HC, Litle VR. miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma. J Thorac Cardiovasc Surg. 2017 Aug; 154(2):714-727.View Related Profiles. PMID: 28495058.
     
  10. Ståhlberg A, Krzyzanowski PM, Egyud M, Filges S, Stein L, Godfrey TE. Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing. Nat Protoc. 2017 Apr; 12(4):664-682. PMID: 28253235; DOI: 10.1038/nprot.2017.006;.
     
Showing 10 of 84 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 84 publications over 23 distinct years, with a maximum of 11 publications in 2005

YearPublications
19951
19971
19983
19992
20008
20013
20025
20031
20045
200511
20064
20073
20083
20092
20115
20125
20134
20143
20152
20162
20173
20181
20197
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Barrett’s Esophagus
Cancer Genomics
Esophageal Adenocarcinoma
Lung Cancer
Molecular Diagnostics
Translational cancer research

Available to Mentor as: (Review Mentor Role Definitions):
  • Research / Scholarly Mentor
Contact for Mentoring:

700 Albany St Ctr for Adv Biomed Res
Boston MA 02118
Google Map


Godfrey's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department